Budesonide CIR capsules once or twice daily in active Crohn's disease. A randomized placebo controlled study in the USA
โ Scribed by Tremaine, William J.; Hanauer, Stephen B.; Katz, Seymour; Winston, Barry D.; Levine, Jeffrey G.; Persson, Tore; Persson, Anders
- Book ID
- 124138296
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 174 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, doubleโblind, placebo controlled trial involving 311 early PD patients not receiving dopaminer
Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with